The largest database of trusted experimental protocols

Vacuette serum clot activator tube

Manufactured by Greiner
Sourced in Austria

The VACUETTE® serum clot activator tubes are laboratory equipment designed for the collection and separation of serum samples. They contain a clot activator that helps in the coagulation of blood samples, enabling the subsequent separation of serum from the clot.

Automatically generated - may contain errors

8 protocols using vacuette serum clot activator tube

1

FGF2 Quantification in Blood Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were collected using VACUETTE® serum clot activator tubes (456073P, GREINER BIO-ONE). Samples were collected between 12PM and 3PM, after participants had arrived at the lab and completed other study tasks. After allowing samples to clot for 30 minutes at room temperature they were centrifuged for 30 minutes at 4000 rpm, aliquoted and stored at −80°C. FGF2 levels were analyzed using a high-sensitivity enzyme linked immunosorbent assay kit (HSFB00D; R&D Systems). Measurements were performed in triplicates and concentrations calculated using Prism7 (Graph-Pad) according to relevant standard curves.
+ Open protocol
+ Expand
2

Blood Sampling and sNfL Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected in 10 mL Vacuette serum clot-activator tubes (Greiner Bio-one, product number 455092) before 12 AM. Blood was allowed to clot for 30 min at room temperature and serum was stored in aliquots at −80°C in the Auria Biobank (Turku, Finland) within 2 hours of sampling. Frozen samples were shipped on dry ice to Basel, Switzerland, where sNfL concentrations were measured by a single molecule array assay (Simoa Technology).14 15 (link)
+ Open protocol
+ Expand
3

Serum FGF2 Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were collected using VACUETTE® serum clot activator tubes (456073P, GREINER BIO-ONE). After allowing the samples to clot for 30 minutes at room temperature they were centrifuged using a Hettich centrifuge for another 30 minutes at 4000 rpm, aliquoted and stored at −80°C until assayed. FGF2 levels were analyzed using a commercially available high-sensitivity enzyme linked immunosorbent assay (ELISA) kit (HSFB00D; R&D Systems). Measurements were performed in triplicates and concentrations were calculated using Prism7 (Graph-Pad) according to relevant standard curves.
+ Open protocol
+ Expand
4

Perioperative Cortisol Stress Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
For investigation of pre-, peri- and postoperative stress levels and a possible influence of the chosen opioid, solid phase, competitive, chemiluminescent enzyme immunoassay (LKCO1, ImmuliteTM 1000, Siemens Diagnostics, Malvern, PA, USA) was performed to assess the serum cortisol concentrations. For this purpose, blood was taken at 3 hourly intervals preoperatively, as well as 5 min after initiation of the surgery. Additional samples were taken at 15 min intervals between 30 and 120 min., as well as 150 and 180 min. and 6 h postoperatively. All samples were drawn into VACUETTE® Serum Clot Activator Tubes, Greiner Bio-One GmbH, Kremsmuenster, Austria).
+ Open protocol
+ Expand
5

Blood Collection and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
On d 50, blood was collected from 2 birds per pen (16 per treatment) from the wing vein using a 21-gauge needle. It was placed into purple-top EDTA-coated vacutainer tubes and analysed for haematology using an automated IDEXX LaserCyte Hematology Analyzer (IDEXX Laboratories (Pty) Ltd., Johannesburg, South Africa), whilst blood collected into red top Vacuette® Serum Clot Activator tubes without EDTA (Greiner Bio-One, GmbH, Frickenhausen, Germany) was analysed for biochemistry using an automated IDEXX Vet Test Chemistry Analyzer (IDEXX Laboratories (Pty) Ltd., Johannesburg, South Africa).
+ Open protocol
+ Expand
6

Serum Kynurenine Pathway Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected in 10 ml Vacuette® serum clot-activator tubes (Greiner Bio-one, product number 455,092) before 12 AM. Blood was allowed to clot for 30 min at room temperature and serum was stored in aliquots at -80 • C within 2 h of sampling. Serum concentrations of TRP, KYN, 3HK, 3-hydroxyanthranilic acid, QUIN, KYNA, anthranilic acid, xanthurenic acid and picolinic acid were assessed using ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) according to previously published methodology (Galla et al., 2021) .
+ Open protocol
+ Expand
7

Evaluating Blood Chemistry in Mice Treated with Bottlebrush Polymers

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 39

Serum was isolated from freshly acquired blood using a VACUETTE serum clot activator tube (Greiner) and a full blood chemistry panel analysis performed by the Charles River Laboratories. Blood samples were collected 10 w after treatment by cardiac puncture before harvesting the organs of the mice for biodistribution studies.

TABLE 2
Blood chemistry results from mice treated
with PEG30, iPrSi30PEG30, or PhSi30PEG30
bottlebrush polymers as compared to untreated controls.
Blood samples were collected 10 weeks after treatment.
Note: a mild elevation in blood glucose levels
was observed for all three bottlebrush samples.
10 WK10 WK10 WK
Control PEG30iPrSi30PEG30PhSi30PEG30
AssayUnitsMouseBrushBrushBrush
CHOLmg/dL99126124107
TRIGmg/dL86262195194
ALTU/L26202225
ASTU/L16282108121
ALPU/L81768269
GLUmg/dL103293224290
PHOSmg/dL9.2778.411.3
Camg/dL9.110.810.310.9
TPg/dL5.15.75.65.5
ALBg/dL3.03.23.23.2
GLOBg/dL2.12.52.42.3
A/G1.41.31.31.4
BUNmg/dL14151315
CREATmg/dL0.20.10.10.2
TBILmg/dL0.300.330.350.32
NamEq/L151150150
KmEq/L9.49.010.0
ClmEq/L113112113
Na/K16.0616.6715.00

+ Open protocol
+ Expand
8

Purification of Human IgG3 Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
IgG3 was purified from six serum samples (average donor age: 44.5 ± 9 years; three male and three female; details are listed in supplemental Table S1). The serum samples were collected from healthy donors with informed consent in compliance with the institutional ethical board. Venous blood was collected in a 9-ml Vacuette serum clot activator tube (Greiner BioOne, Kremsmünster, Austria) and incubated at room temperature for 30 min, followed by centrifugation for 15 min at 1800 g. The serum fraction was then collected and stored at −20 °C. IgG was isolated by running the serum over a HiTrap Protein G HP column (GE Healthcare, Buckinghamshire, UK) and eluted with 0.1 m glycine-HCl, pH 2.7. The eluate containing IgG was then applied to a HiTrap MabSelect SuRE column packed with recombinant Protein A (GE Healthcare), and the IgG3-containing flow-through was concentrated using an Amicon Ultra-15 centrifugal filter device 10 kDa (Merck Millipore, Darmstadt, Germany) and dialyzed against PBS using a Slide-A-Lizer Dialysis Cassette, 10K MWCO (Dionex/Thermo Scientific, Sunnyvale, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!